SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-304155
Filing Date
2020-11-27
Accepted
2020-11-27 07:38:54
Documents
12
Period of Report
2020-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K d95111d8k.htm   iXBRL 8-K 36423
  Complete submission text file 0001193125-20-304155.txt   158061

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sage-20201127.xsd EX-101.SCH 3064
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20201127_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20201127_pre.xml EX-101.PRE 10949
5 EXTRACTED XBRL INSTANCE DOCUMENT d95111d8k_htm.xml XML 3297
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 201352831
SIC: 2834 Pharmaceutical Preparations